Sponsor
This activity is jointly sponsored by Medical Learning Institute, Inc. (a nonprofit medical accreditation company), and Center of Excellence Media, LLC.

Target Audience
This activity was developed for pharmacists and other healthcare professionals practicing in a managed care environment.

Learning Objectives 
Upon completion of this activity, the participant will be able to:

• Discuss recent advances in the treatment and symptom management of multiple sclerosis (MS)
• Describe patient-tailored treatment approaches for modifying the course of the disease and managing symptoms
• Formulate effective management strategies for improving overall outcomes and quality of life for patients with MS

Commercial Support Acknowledgment
This activity is supported by an educational grant from Acorda Therapeutics.

Instructions for Credit
There is no fee for this activity. To receive credit, participants must read this CE activity in its entirety and complete the posttest and evaluation. The posttest and evaluation can be completed online at www.mlicme.org/P11010E.html. Upon completion of the evaluation and scoring 70% or better on the posttest, you will immediately receive your certificate online. If you do not achieve a score of 70% or better on the posttest, you will be asked to take it again. Please retain a copy of the Certificate for your records.

For questions regarding the pharmacy accreditation of this activity, please contact Medical Learning Institute, Inc., at 609-333-1693 or cgusack@mlicme.org.

Pharmacists’ Designation
Medical Learning Institute, Inc., is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 1.0 contact hour (0.1 CEU) of continuing education credit. The universal activity number for this activity is 0468-9999-11-028-H01-P.

Faculty
Gary M. Owens, MD
President Gary Owens Associates
Philadelphia, PA

Bruce L. Hughes, MD
Associate Professor in Neurology
Des Moines University College of Medicine
Director of Ruan Multiple Sclerosis Center
Mercy Medical Center
Des Moines, IA

Sonya J. Lewis, RPh, MBA
Adjunct Professor of Pharmacy
University of Colorado School of Pharmacy
Lafayette, CO

Disclosures
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers’ bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by MLI for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and Center of Excellence Media, LLC, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CE activity for any amount during the past 12 months.

Planners’ and Managers’ Disclosures
Teresa Haile, RPh, MBA, is the MLI reviewer and has nothing to disclose.

Faculty Disclosures
Gary M. Owens, MD, is Consultant to Allergan, Auxilium Pharmaceuticals, Eyetech, Johnson & Johnson, Lilly, and OncoMed; has received research grants from Centocor Ortho Biotech and Pfizer; and is on the Advisory Boards of Amgen, Lilly, and Pfizer.

Bruce L. Hughes, MD, has received research grants from and is on the Speakers’ Bureau of Acorda, Bayer, Biogen, EMD Serono, and Pfizer.

Sonya J. Lewis, RPh, MBA, is Advisor to Biogen, Merck Serono, Novartis, and Teva.

Disclaimer
The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias toward or promotion for any agent discussed in this program should be inferred.

Estimated time to complete activity: 1 hour